The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Target Advancement Program, 2016The Role of LRRK2 in Neuronal Calcium Maintenance
Study Rationale:
Calcium is essential for neuronal survival and function. Flawed intracellular calcium homeostasis (maintenance) is linked to neurodegeneration. There is, however, a major knowledge... -
Research Grant, 2016Tau Imaging in Parkinson's Disease
Study Rationale:
A substantial proportion of individuals with Parkinson's disease develop cognitive
impairment, or difficulty with thinking abilities. The basis for these changes is poorly
understood. We... -
Research Grant, 2016Clinicopathological Features of LRRK2-related Parkinson's Disease
Study Rationale:
Lewy bodies are aggregates of protein composed primarily of alpha-synuclein. For a century, Lewy bodies in the brain have been known to be a defining pathological feature of Parkinson... -
Target Advancement Program, 2016Role of LRRK2 in Levodopa-induced Dyskinesia
Study Rationale:
Alterations in the gene LRRK2 are associated with inherited forms of Parkinson's disease (PD). Although it remains unclear why changes in LRRK2 cause the disease, the majority of... -
Therapeutic Pipeline Program, 2016Structure Window into LRRK2: Kinase or Pseudokinase?
Study Rationale:
Our present understanding of LRRK2 is held back by a lack of structural information. Our
interdisciplinary team will solve structures of specific familial (inherited) mutants of LRRK2... -
Research Grant, 2016Structural Studies on LRRK2 Kinase Using X-Ray Crystallography
Promising Outcomes of Original Grant:
Our initial grant, led by Dr. Susan Taylor, focused on the structural organization of a protein called LRRK2, an enzyme that transfers small chemical groups called...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.